Savara: The Binary Bet On Phase 3 Data
Seeking Alpha,
Follow Summary Savara is a biotech company focusing on the treatment of autoimmune pulmonary alveolar proteinosis.
Follow Summary Savara is a biotech company focusing on the treatment of autoimmune pulmonary alveolar proteinosis.
November 24, 2021 4 min read Source/Disclosures Published by: Source: Orfali N, et al.
This article was originally published here Front Immunol. 2021 Aug 17;12:706186.
. 2021-08-17 LEXINGTON, Mass., Aug. 17, 2021 /PRNewswire/ -- Partner Therapeutics, Inc.